Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Predictors of Survival
BACKGROUND: Transarterial chemoembolization (TACE) is the mainstay of management for patients with hepatocellular carcinoma who are not suitable for curative treatments.
Saved in:
| Main Authors: | Summit Sawhney, Aldo J Montano-Loza, Peter Salat, Mairin McCarthy, Norman Kneteman, Judith Meza-Junco, Richard Owen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2011/864234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frailty as a Predictor of Complications and Transplant-Free Survival after Transarterial Chemoembolization of Hepatocellular Carcinoma
by: Rana Rabei, et al.
Published: (2023-04-01) -
Predictors of Refractoriness and Survival following Transarterial Chemoembolization for Hepatocellular Carcinoma: Outcomes from a Southeast Asian Cohort
by: Rudolf V. Kuhn, et al.
Published: (2023-12-01) -
Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01) -
Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma
by: Meng Zhao, et al.
Published: (2025-02-01) -
The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
by: Seong Kyun Na, et al.
Published: (2018-01-01)